Labcorp Exceeds Q4 Estimates and Projects Strong Revenue Growth Through 2025
Key Insights:
* Labcorp forecasts 2025 revenue exceeding Wall Street expectations, citing high demand for diagnostic tests.
* Annual revenue projection of $13.88-$14.05 billion surpasses analysts' average estimate of $13.8 billion.
* Adjusted profit in 2025 anticipated between $15.60 and $16.40 per share, aligning with estimates.
* Peer diagnostics company Quest Diagnostics also outperformed estimates in Q4 revenue and profit.
* Labcorp's Q4 sales increased 9.8% to $3.33 billion, driven by diagnostic test demand.
* Adjusted earnings per share of $3.45 exceeded analysts' forecasts of $3.39.